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Volume 52, Number 2 Abstracts 529Translumbar Embolization for Type II Endoleaks After EVAR: AMulti-
center Retrospective Review
Amelia J. Simpson, Joy Garg, MD, Ralph B. Dilley, MD, David Frankel,
MD, andNikhil Kansal, MD, Department of Vascular Surgery, University of
California, San Diego School of Medicine, La Jolla, CA
Objective: Translumbar embolization (TLE) of type II endoleaks has
been described for the treatment of enlarging aneurysms following EVAR.
This technique is reported to have a very high rate of technical success and
durability. The purpose of this study is to review our experience with TLE in
controlling type II endoleaks, in arresting the increase in aneurysm growth,
and limiting the need for subsequent intervention.
Methods: A retrospective case review was performed on 13 patients
with CT and/or angiographically confirmed type II endoleaks who under-
went TLE at two institutions. Patients were treated with combinations of
stainless-steal coils, Onyx, Cyanoacrylate (NBCA), thrombin, and/or poly
vinyl alcohol (PVA) beads. Success was defined as clear resolution of the type
II endoleak and/or an aneurysm diameter that was either stable or decreas-
ing. Failure of the technique was defined as any persistent leak, an enlarging
aneurysm sac, or the need for secondary intervention.
Results: Thirteen patients underwent TLE for type II endoleaks asso-
ciated with aneurysm enlargement. In two patients who underwent trans-
lumbar puncture, no endoleak could be identified, and no treatment was
performed. TLE was successful in only 5 (45.5%) of the remaining 11
patients. Six patients (54.5%) had unsuccessful TLE. Of the 6 treatment
failures; 2 patients required repeat interventions, 2 required open surgical
repair (1 for rupture), 1 suffered colonic ischemia requiring resection, and 1
patient has a persistent type II endoleak.
Conclusions: Our experience contrasts with previously published
studies in that fewer than half of the patients treated had successful
resolution of their endoleak with TLE alone. Although TLE is a useful
technique for the management of type II endoleaks, many patients will
require subsequent procedures. Close surveillance of patients after TLE is
imperative to identify the patients who will require additional interven-
tion. The practice gap addressed is the difficulty in obtaining adequate
results using TLE in treating endoleaks. A small number of previously
published studies showed high success rates. By identifying a lower
success rate for TLE, we hope to impress the importance of vigorous
surveillance after the procedure.
The Transition from Custom-Made to Standardized Multi-Branched
Thoracoabdominal Aortic Stent Grafts
Timothy A. Chuter, MD, Ki-Hyuk Park, MD, Jade S. Hiramoto, MD, and
LindaM. Reilly, MD, UCSF, San Francisco, CA, Daegu, Republic of Korea,
and San Francisco, CA
Objective: To compare the branch morphology and short-term out-
come of endovascular aneurysm repair using custom-made vs standardized
multi-branched thoracoabdominal stent grafts.
Methods: Custom-made stent grafts (CSG) with patient-specific cuff
locations were compared with standardized stent grafts (SSG) with uniform
cuff locations. Data on patient demographics, aortic morphology, compo-
nent use, and outcome were collected prospectively. Final branch length
(cuff to target artery orifice) and branch angle (cuff orientation to target
artery orientation) were determined using 3-D reconstruction of computed
tomography angiograms (CTA).
Results: Since January 2008, 24 patients underwent endovascular
repair using 13 CSG (10 in 2008, 3 in 2009) and 11 SSG (1 in 2008, 10 in
2009). Two SSG patients were excluded from analysis: one has yet to
undergo CTA, the other had crossed renal branches due to problems
traversing a previously reconstructed aortic arch. All stent grafts were im-
planted successfully. There were no perioperative deaths. All branches were
patent on the initial postoperative CTA. There were no statistically signifi-
cant differences between the CSG and SSG groups in terms of patient
demographics, procedural details (operation length, fluoroscopy time, con-
trast volume, blood loss), or mean branch length and angle (Table).
Conclusions: The substitution of SSG for CSG had no effect on the
complexity of the procedure, the final branch morphology, or the perioper-
Table. Comparison of branch morphology between custo
Target artery
Mean branch angle (degrees)
CSG (sd) SSG (sd)
CA (n  22) 14.5 (13.3) 20.4 (11.2)
SMA (n  22) 25.6 (18.6) 17.3 (17.6)
RRA (n  21) 25.3 (19.9) 25.0 (14.6)
LRA (n  21) 26.1 (23.0) 28.7 (25.0)
All (n  86) 22.8 (19.0) 22.9 (17.6) 0ative outcome. The availability of an off-the-shelf SSG will broaden the
application of endovascular TAAA repair by eliminating manufacturing
delays.
The Hybrid Procedure: Arch and Visceral/Renal Debranching Com-
bined with Endovascular Repair for Thoracic/Thoracoabdominal Aor-
tic Aneurysms
Sung W. Ham, MD, Terry J. Chong, MD, Vincent L. Rowe, MD, Mark J.
Cunningham, MD, Robbin G. Cohen, MD, and Fred A. Weaver, MD,
Surgery, University of Southern California, Los Angeles, CA
Objective: To report a single-center experience using a hybrid proce-
dure (open debranching, followed by endovascular aortic repair) for treat-
ment of thoracic/thoracoabdominal aortic aneurysms.
Methods: From 2005-2010, 48 patients (31 men; mean age, 71)
underwent a hybrid procedure for thoracic/thoracoabdominal aortic aneu-
rysms. Thirty-day, in-hospital morbidity, and mortality; and late endoleak,
graft patency, and survival were analyzed. Graft patency was assessed by CT,
angiography, or duplex ultrasound.
Results:Hybrid procedures were used to treat 24 thoracic (11 arch, 13
descending), 19 thoracoabdominal (Crawford type I-III: 3, type IV: 7, type
V: 9), and 5 para-anastomotic aortic aneurysms. The hybrid procedure
involved debranching arch vessels (47) or visceral/renal vessels (73) using
bypass grafts, followed by endovascular repair. Eighty percent of debranch-
ing and endovascular repair procedures were staged, with an average interval
of 25 days. Major 30-day and in-hospital complications occurred in 38% of
patients, and included bypass graft occlusion (4), endoleak reintervention
(2), and paraplegia (1). Thirty-day and in-hospital mortality was 4.2%,
secondary to bowel ischemia in one patient and aneurysm rupture in the
other. During a mean follow-up of 13 months, three type II endoleaks
required four interventions. Seven patients died: one of sepsis, one of
respiratory failure, and five of unknown cause. There were no documented
aneurysm-related deaths or new graft or limb occlusions. Primary bypass
graft patency was 96%. Actuarial survival was 85% at 1 year and 67% at 3
years.
Conclusions: The hybrid procedure for the treatment of thoracic/
thoracoabdominal aortic aneurysms is a competitive alternative to traditional
open repair and endovascular repair with branched stent grafts. The results
validate this approach for the short-term to midterm; however, longer
follow-up is required to appraise its durability.
Does Anticoagulation and/or Antiplatelet Treatment Influence the
Incidence Early Type II Endoleaks and Increase the Need for Post-
EVAR Reintervention?
Rafael Lemus-Rangel, MD, General Surgery, Kaiser Permanente Los Ange-
les Medical Center, Los Angeles, CA
Objective: The most common complication after endovascular aneu-
rysm repair (EVAR) is a type II endoleak. The purpose of this study is to
determine the incidence of early endoleak and the rate of post-EVAR
reinterventions in the setting of chronic anticoagulation (Coumadin) and
antiplatelet (AP) therapy.
Methods: A retrospective review of 366 patients undergoing an EVAR
over a 5-year period was performed. Patients were stratified according to the
type of oral anticoagulation therapy and AP treatment. Those treated with a
single oral antiplatelet (ASA or Plavix), dual AP, Coumadin, or combined
AP agent and Coumadin comprised the study groups. The control group
was defined as patients with healthy coagulation and platelet profiles. Fur-
ther group analysis included the incidence of endoleak and the need for
reintervention.
Results: A total of 324 men and 42 women (mean 74  8 [SD] years;
range, 48-90 years) underwent EVAR with a mean AAA size of 5.96 1.16
cm (range, 3-10 cm). Time to CT scan was 97.05  135.24 days (range,
3-1528 days). Irrespective of AP or anticoagulation profile, the overall
incidence of type II endoleak was 18% (67 of 366). The combination of AP
and Coumadin therapy resulted in 45% incidence (9 of 20, P .001), while
ade and standardized stent grafts
Mean branch length (mm)
alue CSG (sd) SSG (sd) P-value
.29 25.1 (15.7) 20.2 (8.1) 0.40
.31 27.0 (12.5) 19.6 (3.0) 0.10
.96 23.5 (11.3) 24.9 (11.6) 0.78
.81 25.3 (8.4) 27.3 (10.6) 0.64m-m
P-v
0
0
0
0
.98 25.3 (12.0) 23.0 (9.1) 0.33
